Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
Comments of the Biotechnology Innovation…
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
Learn more
BIO Comments to FWS on Use of GMOs on National…
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
Learn more
BIO Comments to the Minnesota Department of…
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.    
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Results
Biodefense: 2010 National Security Strategy
March 10, 2016
May 2010 National Security Strategy from the White House
Amendment to Federal Register Notice: NIST issues amendments 2010 TIP competition
March 10, 2016
NIST clarifies that device development is not a focus of 2010 TIP competition.
Vaccines: 2008 Draft Strategic National Vaccine Plan
March 10, 2016
The National Vaccine Program was established in 1986 to achieve optimal prevention of infectious diseases through immunization and optimal prevention of adverse reactions to vaccines.
Agriculture and Weed Resistance
March 10, 2016
The environmental challenges of weed resistance are the same for biotech crops and conventional crops if farmers do not use herbicides as directed. Learn more about stewardship practices that help farmers better control weeds and how biotechnology…
Vaccines: 2009-H1N1 Influenza NVAC Vaccination Program Financing
March 10, 2016
This Report contains NVAC recommendations based on the Working Group’s findings and conclusions, and includes recommendations developed by the NVAC Adolescent Working Group. It takes into account public comments and extensive stakeholder input…
Biodefense: 2009 National Strategy for Countering Biological Threats
March 10, 2016
White House National Security Council - November 2009 National Strategy for Countering Biological Threats
Sarbanes Oxley 404(b) recommendations made by the 2009 Government-Business Forum on Small Business Capital Formation
March 10, 2016
The 2009 Government-Business Forum on Small Business Capital Formation recommended a permanent exemption for small companies from Section 404(b) of Sarbanes-Oxley. Additionally, they recommended that the SEC increase the public float threshold for…
Cures Acceleration Network: BIO Strongly Supports the CAN Program
March 10, 2016
Implementation of CAN will help NIH-funded researchers bridge the precarious gap between basic research and the eventual development of new cures and treatments for many of the diseases we face today.
Pilot Circuit Breaker Proposal: SEC issues proposal on pilot circuit breaker program to combat abusive short selling
March 10, 2016
BIO commends the SEC on its pilot circuit breaker proposal and urges the use of biotech companies in such proposal
Cures Acceleration Network: Patient Group Letter
March 10, 2016
The letter, signed by approximately 85 patient groups, requests appropriation for CAN in FY2011